HutchMED (China) LIMITED Increase (Decrease) in Accounts Payable
HutchMED (China) LIMITED (HCM) reported Increase (Decrease) in Accounts Payable of $3.01 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-03-05
- HutchMED (China) LIMITED increase (decrease) in accounts payable for the quarter ending 2019-12-31 was $932.00K, a 80.23% decline year-over-year.
- HutchMED (China) LIMITED increase (decrease) in accounts payable for the quarter ending 2019-09-30 was -$3.12M, a 294.39% decline year-over-year.
- HutchMED (China) LIMITED increase (decrease) in accounts payable for the quarter ending 2019-06-30 was -$4.62M, a 281.28% decline year-over-year.
- HutchMED (China) LIMITED increase (decrease) in accounts payable for the quarter ending 2019-03-31 was $5.14M.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 6 month as first filed | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month | Increase (Decrease) in Accounts Payable 12 month as first filed |
|---|---|---|---|---|---|---|
| 2025-12-31 | $3.01M 20-F · filed 2026-03-05 | |||||
| 2025-06-30 | $1.20M 6-K · filed 2025-08-07 | |||||
| 2024-12-31 | $6.19M 20-F · filed 2026-03-05 | |||||
| 2024-06-30 | $7.07M 6-K · filed 2025-08-07 | |||||
| 2023-12-31 | -$32.54M 20-F · filed 2026-03-05 | |||||
| 2023-06-30 | -$16.54M 6-K · filed 2024-07-31 | |||||
| 2022-12-31 | $29.94M 20-F · filed 2025-03-19 | |||||
| 2022-06-30 | $9.83M 6-K · filed 2023-07-31 | |||||
| 2021-12-31 | $9.56M 20-F · filed 2024-02-28 | |||||
| 2021-06-30 | -$3.10M 6-K · filed 2022-08-01 | |||||
| 2020-12-31 | $7.65M 20-F · filed 2023-02-28 | |||||
| 2020-06-30 | $1.91M 6-K · filed 2021-07-28 | |||||
| 2019-12-31 | $932.00K derived: 20-F 12 month − 6-K 9 month · filed 2022-03-03 | -$2.18M derived: sum of 2 quarters · filed 2022-03-03 | -$6.80M derived: sum of 3 quarters · filed 2022-03-03 | -$1.66M 20-F · filed 2022-03-03 | ||
| 2019-09-30 | -$3.12M derived: 6-K 9 month − 6-K 6 month · filed 2020-01-21 | -$7.74M derived: sum of 2 quarters · filed 2020-07-30 | -$2.60M 6-K · filed 2020-01-21 | $2.12M derived: sum of 4 quarters · filed 2021-03-04 | ||
| 2019-06-30 | -$4.62M derived: 6-K 6 month − 6-K 3 month · filed 2020-07-30 | $520.00K 6-K · filed 2020-07-30 | $5.23M derived: sum of 3 quarters · filed 2021-03-04 | $6.84M derived: sum of 4 quarters · filed 2021-03-04 | ||
| 2019-03-31 | $5.14M 6-K · filed 2019-06-06 | $9.85M derived: sum of 2 quarters · filed 2021-03-04 | $11.46M derived: sum of 3 quarters · filed 2021-03-04 | $14.00M derived: sum of 4 quarters · filed 2021-03-04 | ||
| 2018-12-31 | $4.71M derived: 20-F 12 month − 6-K 9 month · filed 2021-03-04 | $6.32M derived: sum of 2 quarters · filed 2021-03-04 | $8.87M derived: sum of 3 quarters · filed 2021-03-04 | $1.26M 20-F · filed 2021-03-04 | ||
| 2018-09-30 | $1.60M derived: 6-K 9 month − 6-K 6 month · filed 2020-01-21 | $4.15M derived: sum of 2 quarters · filed 2020-01-21 | -$3.45M 6-K · filed 2020-01-21 | |||
| 2018-06-30 | $2.55M derived: 6-K 6 month − 6-K 3 month · filed 2019-07-30 | -$5.06M 6-K · filed 2019-07-30 | ||||
| 2018-03-31 | -$7.61M 6-K · filed 2019-06-06 | |||||
| 2017-12-31 | -$11.17M 20-F · filed 2020-03-03 | |||||
| 2017-06-30 | -$2.88M 6-K · filed 2018-07-27 | -$3.12M 6-K · filed 2017-07-31 | ||||
| 2016-12-31 | $11.45M 20-F · filed 2019-03-11 | $9.82M 20-F · filed 2017-03-13 | ||||
| 2016-06-30 | $3.58M 6-K · filed 2017-07-31 | |||||
| 2015-12-31 | $3.66M 20-F · filed 2018-03-12 | $2.33M 20-F · filed 2017-03-13 | ||||
| 2014-12-31 | $2.33M 20-F · filed 2017-03-13 |